Blueprint Medicines Corporation (LON:0HOJ)

Blueprint Medicines Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	102.01	71.29	119.71	209.95	684.64
Short-Term Investments	513.47	639.36	825.28	267.17	187.21
Cash & Short-Term Investments	615.49	710.64	944.99	477.11	871.85
Cash Growth	-13.39%	-24.80%	98.06%	-45.28%	80.30%
Receivables	77.61	43.18	36.94	37.03	25.31
Inventory	13.61	21.22	29.7	21.82	8.58
Prepaid Expenses	35.97	33.35	35.02	18.06	22.02
Total Current Assets	742.68	808.39	1,047	554.03	927.76
Property, Plant & Equipment	100.77	115.65	115.2	120.86	101.67
Long-Term Investments	277.15	84.32	161.27	557.53	677.87
Other Long-Term Assets	59.21	40.89	26.78	19.81	11.09
Total Assets	1,180	1,049	1,350	1,252	1,718
Accounts Payable	6.79	4.71	2.73	8.33	4.37
Accrued Expenses	102.27	110.53	122.08	117.9	104.97
Current Portion of Long-Term Debt	105.57	69.48	34.14	-	-
Current Portion of Leases	13.35	11.93	10.58	8.09	7.94
Current Unearned Revenue	2.01	0.81	4.67	11.51	12.56
Other Current Liabilities	30.82	17.47	9.05	3.93	0.97
Total Current Liabilities	260.8	214.92	183.23	149.77	130.8
Long-Term Debt	536.58	610.96	535.28	-	-
Long-Term Leases	68.79	81.75	92.79	103.32	81.67
Long-Term Unearned Revenue	8.19	4.79	13.62	25.07	28.6
Other Long-Term Liabilities	6.79	6.21	10.3	3.34	7.24
Total Liabilities	881.15	918.64	835.23	281.49	248.31
Common Stock	0.06	0.06	0.06	0.06	0.06
Additional Paid-In Capital	2,709	2,474	2,358	2,250	2,107
Retained Earnings	-2,407	-2,340	-1,833	-1,275	-631.36
Comprehensive Income & Other	-3.55	-3.5	-10.44	-4.13	-5.21
Total Common Equity	298.67	130.61	514.68	970.74	1,470
Shareholders' Equity	298.67	130.61	514.68	970.74	1,470
Total Liabilities & Equity	1,180	1,049	1,350	1,252	1,718
Total Debt	724.28	774.12	672.78	111.41	89.6
Net Cash (Debt)	139.66	-6.95	405.69	923.24	1,460
Net Cash Growth	-	-	-56.06%	-36.77%	223.03%
Net Cash Per Share	2.22	-0.11	6.80	15.78	26.00
Filing Date Shares Outstanding	63.91	61.23	59.98	59.2	57.96
Total Common Shares Outstanding	63.71	61.15	59.96	59.14	57.79
Working Capital	481.88	593.47	863.42	404.26	796.96
Book Value Per Share	4.69	2.14	8.58	16.41	25.44
Tangible Book Value	298.67	130.61	514.68	970.74	1,470
Tangible Book Value Per Share	4.69	2.14	8.58	16.41	25.44
Machinery	32.42	27.98	21.32	18.55	16.35
Construction In Progress	0.24	9.51	1.61	0.21	0.15
Leasehold Improvements	50.79	42.3	41.05	36.95	36.95

Source: S&P Capital IQ. Standard template. Financial Sources.